Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX

Capital Research Global Investors reported a 5.70% stake in Vertex Pharmaceuticals Incorporated (Schedule 13G)

Event Mar 31, 2025 · Filed May 13, 2025

Capital Research Global Investors reported a 5.70% stake in Vertex Pharmaceuticals Incorporated, 14,536,344 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G).

Stake
5.70%
Shares
14,536,344
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
Capital Research Global Investors5.70%14,536,344

Source

View original at SEC

Related